share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

辉瑞 | 4:持股变动声明-高管 BOURLA ALBERT
美股SEC公告 ·  07/12 13:27
Moomoo AI 已提取核心信息
Pfizer Inc. (PFE) has reported a transaction involving its Chairman & CEO, Albert Bourla. The transaction took place on 07/11/2024. However, the announcement did not disclose specific details regarding the number of shares transacted, the nature of the shares, the transaction price, or the total value of the shares. Additionally, the number of shares held by Bourla after the transaction was not provided. Investors are advised to await further details to fully assess the impact of this transaction on their investment decisions.
Pfizer Inc. (PFE) has reported a transaction involving its Chairman & CEO, Albert Bourla. The transaction took place on 07/11/2024. However, the announcement did not disclose specific details regarding the number of shares transacted, the nature of the shares, the transaction price, or the total value of the shares. Additionally, the number of shares held by Bourla after the transaction was not provided. Investors are advised to await further details to fully assess the impact of this transaction on their investment decisions.
辉瑞公司(PFE)报告了其董事长兼首席执行官Albert Bourla的一笔交易。该交易发生在2024年07月11日。但是,公告未披露有关转让股份数量、股份性质、交易价格或股份总价值的具体细节。此外,Bourla交易后持有的股份数量也未提供。建议投资者等待进一步详情以充分评估此交易对他们的投资决策的影响。
辉瑞公司(PFE)报告了其董事长兼首席执行官Albert Bourla的一笔交易。该交易发生在2024年07月11日。但是,公告未披露有关转让股份数量、股份性质、交易价格或股份总价值的具体细节。此外,Bourla交易后持有的股份数量也未提供。建议投资者等待进一步详情以充分评估此交易对他们的投资决策的影响。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息